Regeneron Appoints Bayer's David Weinreich As SVP
This article was originally published in Scrip
Regeneron Pharmaceutical, Inc. has appointed David Weinreich senior vice president late stage clinical development and medical affairs. With over 15 years' experience, Weinreich was previously senior vice president and head of global development for speciality medicine at Bayer Pharmaceuticals. Prior to this, he held various senior roles at Amgen in the oncology and development organization.
Register for our free email digests: